Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy

Authors: Laurent Michel, Marie Jauffret-Roustide, Jerôme Blanche, Olivier Maguet, Christine Calderon, Julien Cohen, Patrizia M Carrieri, ANRS PRI²DE study group

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines.

Methods

A nationwide survey targeting the heads of medical (all French prisons) and psychiatric (26 French prisons) units was conducted using a postal questionnaire and a phone interview mainly focusing on access to prevention interventions, i.e. bleach, opioid substitution treatment (OST), HBV vaccination and post-exposure prophylaxis (PEP) for French prisoners. Two scores were built reflecting adherence to national and WHO international guidelines, ranging from 0 (no adherence) to 10 (maximum adherence) and 0 to 9 respectively.

Results

A majority (N = 113 (66%)) of the 171 prisons answered the questionnaires, representing 74% coverage (46,786 prisoners) of the French prison population: 108 were medical units and 12 were psychiatric units. Inmate access to prevention was poor. The median[IQR] score measuring adherence to national guidelines was quite low (4.5[2.5; 5.5]) but adherence to WHO guidelines was even lower 2.5[1.5; 3.5]; PEP was absent despite reported risky practices. Unsuitable OST delivery practices were frequently observed.

Conclusions

A wide gap exists between HIV prevention policies and their application in prisons. Similar assessments in other countries may be needed to guide a global policy reform in prison settings. Adequate funding together with innovative interventions able to remove structural and ideological barriers to HIV prevention are now needed to motivate those in charge of prison health, to improve their working environment and to relieve French prisoners from their currently debilitating conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fazel S, Baillargeon J: The health of prisoners. Lancet. 2010 Fazel S, Baillargeon J: The health of prisoners. Lancet. 2010
2.
go back to reference Dolan K, Kite B, Black E, Aceijas C, Stimson GV: HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007, 7 (1): 32-41. 10.1016/S1473-3099(06)70685-5.CrossRefPubMed Dolan K, Kite B, Black E, Aceijas C, Stimson GV: HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007, 7 (1): 32-41. 10.1016/S1473-3099(06)70685-5.CrossRefPubMed
3.
go back to reference Jurgens R, Ball A, Verster A: Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis. 2009, 9 (1): 57-66. 10.1016/S1473-3099(08)70305-0.CrossRefPubMed Jurgens R, Ball A, Verster A: Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis. 2009, 9 (1): 57-66. 10.1016/S1473-3099(08)70305-0.CrossRefPubMed
4.
go back to reference WHO: Effectiveness of interventions to address HIV in prisons. Evidence for action technical papers. 2007, Geneva: WHO-UNODC-UNAIDS WHO: Effectiveness of interventions to address HIV in prisons. Evidence for action technical papers. 2007, Geneva: WHO-UNODC-UNAIDS
5.
go back to reference Fazel S, Bains P, Doll H: Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006, 101 (2): 181-191. 10.1111/j.1360-0443.2006.01316.x.CrossRefPubMed Fazel S, Bains P, Doll H: Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006, 101 (2): 181-191. 10.1111/j.1360-0443.2006.01316.x.CrossRefPubMed
6.
go back to reference Falissard B, Loze JY, Gasquet I, Duburc A, de Beaurepaire C, Fagnani F, Rouillon F: Prevalence of mental disorders in French prisons for men. BMC Psychiatry. 2006, 6: 33-10.1186/1471-244X-6-33.CrossRefPubMedPubMedCentral Falissard B, Loze JY, Gasquet I, Duburc A, de Beaurepaire C, Fagnani F, Rouillon F: Prevalence of mental disorders in French prisons for men. BMC Psychiatry. 2006, 6: 33-10.1186/1471-244X-6-33.CrossRefPubMedPubMedCentral
7.
go back to reference Fazel S, Danesh J: Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. Lancet. 2002, 359 (9306): 545-550. 10.1016/S0140-6736(02)07740-1.CrossRefPubMed Fazel S, Danesh J: Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. Lancet. 2002, 359 (9306): 545-550. 10.1016/S0140-6736(02)07740-1.CrossRefPubMed
8.
go back to reference Knapp A: A retro disease on the loose. Rise of hepatitis C in prisons may fuel outbreak in general population. Mod Healthc. 2005, 35 (17): 34.-PubMed Knapp A: A retro disease on the loose. Rise of hepatitis C in prisons may fuel outbreak in general population. Mod Healthc. 2005, 35 (17): 34.-PubMed
9.
go back to reference Timbart O: Les condamnations en 2008. Secrétariat Général, Service support et moyens du ministère, Sous-direction de la Statistique et des Études. 2009, Paris: Ministère de la Justice Timbart O: Les condamnations en 2008. Secrétariat Général, Service support et moyens du ministère, Sous-direction de la Statistique et des Études. 2009, Paris: Ministère de la Justice
10.
go back to reference Ministry of Health/Justice: Guide méthodologique relatif à la prise en charge sanitaire des personnes détenues. 2004, Paris Ministry of Health/Justice: Guide méthodologique relatif à la prise en charge sanitaire des personnes détenues. 2004, Paris
11.
go back to reference Ministry of Health/Justice: Circulaire n°739, 5 December 1996: Measures to fight against AIDS in prison setting. DGS/DH/DAP. 1996 Ministry of Health/Justice: Circulaire n°739, 5 December 1996: Measures to fight against AIDS in prison setting. DGS/DH/DAP. 1996
12.
go back to reference Michel L, Carrieri MP, Wodak A: Harm reduction and equity of access to care for French prisoners: a review. Harm Reduct J. 2008, 5: 17-10.1186/1477-7517-5-17.CrossRefPubMedPubMedCentral Michel L, Carrieri MP, Wodak A: Harm reduction and equity of access to care for French prisoners: a review. Harm Reduct J. 2008, 5: 17-10.1186/1477-7517-5-17.CrossRefPubMedPubMedCentral
13.
go back to reference Carrieri MP, Rey D, Michel L: Universal hepatitis B virus vaccination in French prisons: breaking down the last barriers. Addiction. 2010, 105 (7): 1311-1312. 10.1111/j.1360-0443.2010.02968.x.CrossRefPubMed Carrieri MP, Rey D, Michel L: Universal hepatitis B virus vaccination in French prisons: breaking down the last barriers. Addiction. 2010, 105 (7): 1311-1312. 10.1111/j.1360-0443.2010.02968.x.CrossRefPubMed
14.
go back to reference Backmund M, Meyer K, Schuetz C, Reimer J: Factors associated with exposure to hepatitis B virus in injection drug users. Drug Alcohol Depend. 2006, 84 (2): 154-159. 10.1016/j.drugalcdep.2006.01.009.CrossRefPubMed Backmund M, Meyer K, Schuetz C, Reimer J: Factors associated with exposure to hepatitis B virus in injection drug users. Drug Alcohol Depend. 2006, 84 (2): 154-159. 10.1016/j.drugalcdep.2006.01.009.CrossRefPubMed
15.
go back to reference Small W, Kain S, Laliberte N, Schechter MT, O'Shaughnessy MV, Spittal PM: Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse. 2005, 40 (6): 831-843. 10.1081/JA-200030795.CrossRefPubMed Small W, Kain S, Laliberte N, Schechter MT, O'Shaughnessy MV, Spittal PM: Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse. 2005, 40 (6): 831-843. 10.1081/JA-200030795.CrossRefPubMed
16.
go back to reference Correctional Service Canada: Evaluation of HIV/AIDS Harm Reduction Measures in the Correctional Service of Canada. 1999, Ottawa: CSC Correctional Service Canada: Evaluation of HIV/AIDS Harm Reduction Measures in the Correctional Service of Canada. 1999, Ottawa: CSC
17.
go back to reference Dolan K, Shearer J, Hall WD, Wodak A: Bleach is easier to obtain but inmates are still at risk of infection in New South Wales prisons. NDARC Technical Report 34. 1996, Sydney: National Drug and Alcohol Research Centre, University of New South Wales Dolan K, Shearer J, Hall WD, Wodak A: Bleach is easier to obtain but inmates are still at risk of infection in New South Wales prisons. NDARC Technical Report 34. 1996, Sydney: National Drug and Alcohol Research Centre, University of New South Wales
18.
go back to reference Dolan K, Wodak A, Hall W: HIV risk behavior and prevention in prison: a bleach program for inmates in NSW. Drug Alcohol Review. 1999, 18: 139-143. 10.1080/09595239996563.CrossRef Dolan K, Wodak A, Hall W: HIV risk behavior and prevention in prison: a bleach program for inmates in NSW. Drug Alcohol Review. 1999, 18: 139-143. 10.1080/09595239996563.CrossRef
19.
go back to reference MacDonald M: A Study of health care provision, existing drug services and strategies operating in prisons in ten countries from Central and Eastern Europe. 2005, Helsinki: The European Institute for Crime Prevention and Control. HEUNI MacDonald M: A Study of health care provision, existing drug services and strategies operating in prisons in ten countries from Central and Eastern Europe. 2005, Helsinki: The European Institute for Crime Prevention and Control. HEUNI
21.
go back to reference Jauffret-Roustide M, Le Strat Y, Couturier E, Thierry D, Rondy M, Quaglia M, Razafandratsima N, Emmanuelli J, Guibert G, Barin F, Desenclos JC: A national cross-sectional study among drug-users in France: Epidemiology of HCV and highlight on practical and statistical aspects of the design. BMC Infect Dis. 2009, 9 (1): 113.-10.1186/1471-2334-9-113.CrossRefPubMedPubMedCentral Jauffret-Roustide M, Le Strat Y, Couturier E, Thierry D, Rondy M, Quaglia M, Razafandratsima N, Emmanuelli J, Guibert G, Barin F, Desenclos JC: A national cross-sectional study among drug-users in France: Epidemiology of HCV and highlight on practical and statistical aspects of the design. BMC Infect Dis. 2009, 9 (1): 113.-10.1186/1471-2334-9-113.CrossRefPubMedPubMedCentral
22.
go back to reference Greenwald G: Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. 2009, Washington, D.C.: CATO Institute Greenwald G: Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. 2009, Washington, D.C.: CATO Institute
Metadata
Title
Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy
Authors
Laurent Michel
Marie Jauffret-Roustide
Jerôme Blanche
Olivier Maguet
Christine Calderon
Julien Cohen
Patrizia M Carrieri
ANRS PRI²DE study group
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-400

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue